Saw this article and wish to share it you all
simvastatin
Zocor
Pharmaceutical company:
Merck & Co., Inc.
www.merck.com
NEW WARNING
The Food and Drug Administration (FDA) issued a warning to patients and health care providers about an increased risk of muscle injury, including rhabdomyolysis, in patients taking the highest approved dose (80 mg) of simvastatin (Zocor) when compared to patients taking lower doses of simvastatin and, possibly, other statins in higher doses. Rhabdomyolysis, the most serious form of muscle injury, can lead to kidney failure and sometimes death. The FDA reviewed clinical trials, observational studies, adverse event reports, and prescription data to gain this new information.
Simvastatin, indicated for lowering cholesterol levels, is also available in combinations with ezetimibe or niacin (marketed under the brand names Vytorin and Simcor, respectively). Health care professionals should consider the risks and benefits of simvastatin before prescribing the drug.
Brought to you by Lippincott Williams & Wilkins.
